Interesting, these trials are to study and further develop ERP/EEG biomarker measures.
Primary objectives are to quantify the effect size of ketamine-induced changes on MMN from a duration-deviant auditory oddball ERP test and to quantify the variability of ketamine-induced changes on MMN from a duration-deviant auditory oddball ERP test.
Interesting pure scientific research in partnership with an interesting cast of companies participating.
Alkermes, Inc. Anavex Life Sciences Corp. Astellas Pharma Inc H. Lundbeck A/S Merck Sharp & Dohme Corp. Novartis Sage Therapeutics Takeda Apex Innovative Sciences COGNISION